Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in North America has been steadily growing over the years.
Customer preferences: Customers in North America have shown a preference for prescription drugs over over-the-counter drugs due to the perception that prescription drugs are more effective. Additionally, there is a growing demand for personalized medicine and specialty drugs, which are often used to treat rare diseases.
Trends in the market: One of the major trends in the North American Pharmaceuticals market is the increasing use of biologics, which are drugs made from living cells. Biologics have shown to be effective in treating a range of diseases, including cancer and autoimmune disorders. Another trend is the growing use of digital health technologies, such as telemedicine and health apps, which are changing the way patients access healthcare and manage their health.
Local special circumstances: The United States is the largest market for Pharmaceuticals in North America, and one of the largest in the world. The country's aging population and high prevalence of chronic diseases have contributed to the growth of the market. Canada, on the other hand, has a smaller market size but has a strong focus on research and development, particularly in the areas of oncology and neuroscience.
Underlying macroeconomic factors: The North American Pharmaceuticals market is influenced by a range of macroeconomic factors, including government regulations, healthcare policies, and patent laws. The high cost of healthcare in the United States has led to increased scrutiny of drug prices and calls for greater transparency in pricing. In Canada, the government plays a larger role in setting drug prices, which has led to lower prices compared to the United States. The ongoing COVID-19 pandemic has also had an impact on the market, with increased demand for certain drugs and disruptions to supply chains.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)